- Country: USA
- Summary: Preventive Maintenance Services For One Illumina Microarray Scanner (iScan/RoMa) and Two Illumina Sequencers (NextSeq 550Dx)
- UST Ref No: 116837361
- Deadline: 02 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N91025Q00032
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR) plans to procure, on a sole source basis, preventive maintenance services for one Illumina Microarray Scanner (iScan/RoMa) and two Illumina Sequencers (NextSeq 550Dx) from:
Illumina, Inc
5200 Illumina Way
San Diego CA 92122-4616
The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1 (b)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 811210 and the business size standard is $34.0 million.
The Laboratory of pathology (LP) at the National Cancer Institute uses an Illumina iScan/RoMa microarray scanner system and two Illumina NextSeq 550Dx sequencing instruments for high-throughput, diagnostic assays and multiplex human genotyping microarrays for whole-genome, targeted genome, and exome analyses. These clinical assays are crucial for patient enrollment in NCI clinical protocols and for patient treatments. To generate accurate data, the microarray system and the sequencing systems must be calibrated correctly and maintained according to the manufacturer-s specifications. No inaccuracy or down-time of these instruments can be tolerated as it would severely compromise patient treatment and safety. All data generated must be comparable to what has been historically reported, since any deviation from the design specifications could compromise data integrity of the ongoing clinical trials.
The Government-owned iScan/RoMa microarray scanner system and NextSeq 550Dx sequencing systems must be calibrated accurately and maintained according to the most recent manufacturer-s specifications by authorized OEM trained service engineers. Acc... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPreventive Maintenance Services For One Illumina Microarray Scanner (iScan/RoMa) and Two Illumina Sequencers (NextSeq 550Dx) - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Preventive Maintenance Services For One Illumina Microarray Scanner (iScan/RoMa) and Two Illumina Sequencers (NextSeq 550Dx). This tender is published on USARFP under UST Ref No: 116837361 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-02.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
